Induction of Mixed Hemopoietic Chimerism in Patients Using Fludarabine, Low Dose TBI, PBSC Infusion and Post Transplant in Immunosuppression w/CSA & Mycophenolate Mofetil

Status

UNKNOWN

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00531635

Enrollment

350

Registered

2007-09-19

Start date

2002-07-31

Completion date

2012-06-30

Last updated

2011-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Transplant in Immunosuppression w/CSA & Mycophenolate Mofetil

Keywords

Mixed hemopoietic chimerism, Fludarabine, TBI, PBSC, immunosuppression, Mycophenolate Mofetil

Brief summary

Induction of mixed hemopoietic chimerism in patients using Fludarabine, Low Dose TBI, PBSC Infusion and post transplant in immunosuppression w/CSA & Mycophenolate Mofetil

Interventions

DRUGMycophenolate Mofetil

Induction of Mixed Hemopoietic Chimerism in Patients Using Mycophenolate Mofetil

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Patients receiving Fludarabine, Low Dose TBI, PBSC Infusion and post transplant in immunosuppression w/CSA & Mycophenolate Mofetil.

Exclusion criteria

* Uncontrolled major medical illnesses

Design outcomes

Primary

Measure	Time frame
Efficacy	2001-2012

Countries

Saudi Arabia

Contacts

Primary ContactMahmoud AlJurf, MD

maljurf@kfshrc.edu.sa966-1-4647272

Backup ContactEd Colcol

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026